Ongoing Clinical Trials

Indication
Institution
Department
Principal Investigator
Protocol Title
TMU-JIRB No. Protocol Title Indication Institution Department Principal Investigator Contact
N202104119 SERENA-6: A Phase III, Double-blind, Randomised Study to Assess Switching to AZD9833 (a Next Generation, Oral SERD) + CDK4/6 Inhibitor vs Continuing Aromatase Inhibitor (Letrozole or Anastrozole) + CDK4/6 Inhibitor in HR+/HER2- MBC Patients with Detectable ESR1 Mutation Without Disease Progression During 1L Treatment with Aromatase Inhibitor + CDK4/6 Inhibitor – A ctDNA Guided Early Switch Study Breast Cancer TMUH Hematology and Oncology Jia-Ruey Tsai Yin-Ju Chen
02-27372181 #7606
N202111011 A Randomized Controlled Phase II, Two-Arm Study of Umbilical Cord Blood Cell Trans-plant (MC001) into Injured Spinal Cord followed by the Locomotor Training for Patients with Chronic Spinal Cord Injuries (SCI). Spinal Cord Injuries (SCI) TMUH Neurosurgery Yung-Hsiao,Chiang Wei-Ling Lan
0970405675
N202203154 A Phase 3 Open-Label, Randomized, Controlled, Global Study of Telisotuzumab Vedotin (ABBV-399) Versus Docetaxel in Subjects with Previously Treated c-Met Overexpressing, EGFR Wildtype, Locally Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer Solid tumors TMUH Pulmonary Medicine Shih-Hsin Hsiao Pei-Rong Luo
0911135352
N202207026 A Prospective Observational Human Subject Research to Explore the HLA-A*02:01 Allele Frequency and the NY-ESO-1 Expression Status in Cancer Patients in Taiwan Cancer Patients TMUH Pulmonary Medicine Shih-Hsin Hsiao Yi-Ann Chen
02-27372181 #7633
N202011053 Non-Interventional Collecting Evidences For ILD in Taiwan:Optimized Novel Therapy Interstitial lung disease TMUH Pulmonary Medicine Chi-Li Chung Yin-Ju Chen
02-27372181 #7607
N202108058 Develop the umbilical cord mesenchymal stem cell model from human umbilical cord Cell Therapy WFH Obstetrics/Gynecology Le-Ming Wang Yi-Jie Ding
02-89797888 #118
N202005019 Intracorneal Lenticular Extraction refractive surgery with Femtosecond Ophthalmic laser Femton F1 Femtosecond Ophthalmic WFH Ophthalmology Chien-Liang Wu Hsiu-Yen Wang
0229307930 #2543
N202005020 Femtosecond FLEX Application with Ophthalmic Femton F1 Femtosecond Ophthalmic WFH Ophthalmology Chien-Liang Wu Hsiu-Yen Wang
0229307930 #2544
N202206025 Open-label Extension of the ARGX-113-1802 Trial to Investigate the Long-term Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC in Patients With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Chronic Kidney Disease (CKD) WFH Internal Medicine/Neurology Jia-Ying Sung Hsiu-Chen Chang
0229307930 #2550
N202208004 A Phase 2, Open-Label, Randomized Study to Assess the Efficacy and Safety of Zolbetuximab (IMAB362) in Combination with Nab-Paclitaxel and Gemcitabine (Nab-P + GEM) as First Line Treatment in Subjects with Claudin 18.2 (CLDN18.2) Positive, Metastatic Pancreatic Adenocarcinoma Pancreatic Cancer WFH Hematology And Oncology Tzeon-Jye Chiou Sih-Chen Wang
0958131385
1 2 3 4 5 6 7 8 9 10 11 12 13 / 13

TOP